These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3552025)

  • 1. Influence of underlying disease and donor sex on the incidence of graft-versus-host disease in allogeneic bone marrow transplantation.
    Beelen DW; Quabeck K; Mahmoud HK; Grosse-Wilde H; Shaefer UW; Schmidt CG
    Br J Haematol; 1987 Mar; 65(3):385-6. PubMed ID: 3552025
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone marrow transplantation in patients with leukemia. Incidence and severity of graft-versus-host disease in successful HL-A-matched transplants.
    Graw RG; Santos GW
    Transplantation; 1971 Feb; 11(2):197-9. PubMed ID: 4397090
    [No Abstract]   [Full Text] [Related]  

  • 3. Allogeneic bone marrow transplantation in leukemia.
    Kolb HJ
    Recent Results Cancer Res; 1984; 93():269-89. PubMed ID: 6382484
    [No Abstract]   [Full Text] [Related]  

  • 4. T cells, graft-versus-host disease and graft-versus-leukemia: innovative approaches for blood and marrow transplantation.
    Champlin R; Giralt S; Gajewski J
    Acta Haematol; 1996; 95(3-4):157-63. PubMed ID: 8677736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of the microbial flora on incidence of graft-versus-host disease in human allogeneic bone marrow transplantation.
    Schmeiser T; Kurrle E; Arnold R; Heit W; Krieger D; Kubanek B; Heimpel H
    Prog Clin Biol Res; 1985; 181():433-5. PubMed ID: 3895247
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Perreault C; Gyger M; Boileau J; Bonny Y; Cousineau S; Lacombe M; Lavallee R; Tawil E; D'Angelo G
    Can Med Assoc J; 1983 Nov; 129(9):969-74. PubMed ID: 6367917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia.
    Rondón G; Giralt S; Huh Y; Khouri I; Andersson B; Andreeff M; Champlin R
    Bone Marrow Transplant; 1996 Sep; 18(3):669-72. PubMed ID: 8879640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic bone marrow transplantation.
    Weiden PL
    Crit Rev Clin Lab Sci; 1983; 19(3):173-86. PubMed ID: 6373140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Present status of donor leukocyte transfusion for leukemia. Relapse after allogeneic bone marrow transplantation in Japan].
    Morishima Y; Kodera Y
    Rinsho Ketsueki; 1997 Jun; 38(6):476-8. PubMed ID: 9248321
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of leukemia with partially matched related bone marrow transplantation.
    Munn RK; Henslee-Downey PJ; Romond EH; Marciniak EJ; Fleming DR; Messino MJ; Macdonald JS; Rayens MK; Harder EJ; Phillips GL; Thompson JS
    Bone Marrow Transplant; 1997 Mar; 19(5):421-7. PubMed ID: 9052906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.
    Weiden PL; Sullivan KM; Flournoy N; Storb R; Thomas ED;
    N Engl J Med; 1981 Jun; 304(25):1529-33. PubMed ID: 7015133
    [No Abstract]   [Full Text] [Related]  

  • 12. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
    Du B; Li DP; Xu KL; Pan XY
    Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marrow transplantation for acute leukemia in man.
    Fefer A; Thomas ED; Buckner CD; Cheever MA; Einstein AB; Neiman PE; Storb R; Weiden PL; Clift RA
    Ann N Y Acad Sci; 1976; 277(00):52-9. PubMed ID: 11732
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of bone marrow mesenchymal stem cells on acute graft versus host disease and graft versus leukemia after allogeneic bone marrow transplantation].
    Hu WB; Gao QP; Chen YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):404-7. PubMed ID: 15972130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemia relapse after allogeneic bone marrow transplantation: how does chronic graft-versus-host disease influence the pattern and onset of relapse?
    Al Beihany A; Al Mohareb F; Al Zahrani H; Alsharif F; Chaudhri N; Mohamed SY; Rasheed W; Aljurf M
    Exp Clin Transplant; 2011 Dec; 9(6):432-3. PubMed ID: 22142055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on graft-versus-leukemia effects of donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation].
    Du B; Li D; Xu K
    Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):403-7. PubMed ID: 11718089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic graft-versus-host disease following allogeneic peripheral blood and bone marrow stem cell transplants: a single center experience.
    Takami A; Ishiyama K; Asakura H; Shiobara S; Nakao S
    Haematologica; 2002 Jun; 87(6):664-6. PubMed ID: 12031928
    [No Abstract]   [Full Text] [Related]  

  • 19. Graft versus host disease.
    Ray TL
    Int J Dermatol; 1982 Sep; 21(7):398-9. PubMed ID: 6752054
    [No Abstract]   [Full Text] [Related]  

  • 20. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation.
    Min CK; Kim DW; Lee JW; Min WS; Kim CC
    Acta Haematol; 2000; 104(4):185-92. PubMed ID: 11279309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.